Rosalind Advisors, Inc. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001622627

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q1 2024 · 33 positions · Total reported value $107.02M · Top-10 concentration 58.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 54.8% · 9 new · 11 cut · 3 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +4.7% · vs SPY +2.5% · Prev Value $269.06M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -5.8% · vs SPY -7.9% · Latest Value $244.66M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2024 13F filing, Rosalind Advisors, Inc. disclosed 33 equity positions with a combined reported value of $107.02M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.3% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2024 were MYO ($8.00M), LYRA ($7.12M), MDWD ($6.93M). By sector, the heaviest allocations are Health Care 69.7%, Other 30.3%.

Versus the prior quarter, Rosalind Advisors, Inc. opened 9 new positions, trimmed 11 and fully exited 3, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 55% of names.

The largest new positions opened in Q1 2024 were CYBN ($5.77M), ABVX ($5.41M), CLSD ($3.97M).

Of the 3 positions fully exited versus the prior quarter, the largest were ATXS ($8.67M), SRPT ($6.37M), MDGL ($5.78M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2024)

  • CYBN CYBIN INC · $5.77M
  • ABVX ABIVAX SA · $5.41M
  • CLSD CLEARSIDE BIOMEDICAL INC · $3.97M
  • OTLK OUTLOOK THERAPEUTICS INC · $3.72M
  • UNCY UNICYCIVE THERAPEUTICS INC · $2.59M
  • PYPD POLYPID LTD · $1.91M
  • KPRX KIORA PHARMACEUTICALS INC · $1.62M
  • XAIR BEYOND AIR INC · $1.57M

Fully Exited (vs previous quarter)

  • ATXS ASTRIA THERAPEUTICS INC · prev qtr: $8.67M
  • SRPT SAREPTA THERAPEUTICS INC · prev qtr: $6.37M
  • MDGL MADRIGAL PHARMACEUTICALS INC · prev qtr: $5.78M
  • ASND ASCENDIS PHARMA A/S · prev qtr: $2.12M
  • NVNO ENVVENO MEDICAL CORPORATION · prev qtr: $1.60M
  • RVPH REVIVA PHARMACEUTCLS HLDGS I · prev qtr: $1.01M
  • MACK MERRIMACK PHARMACEUTICALS IN · prev qtr: $804.60K

Insider Transactions (Form 4)

Latest Rosalind Advisors, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-10-13 J DELCATH SYSTEMS, INC. 27,502 — SEC filing
2026-10-13 Conversion DELCATH SYSTEMS, INC. 3,627 — SEC filing

All insider transactions →

Fund Profile

Rosalind Advisors, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 33 US equity positions with a combined value of $269.06M. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Portfolio Structure

  • 33 positions · $269.06M reported value (Q2 2026)
  • Top 10 holdings = 74.1% of reported value
  • Largest position: DCTH (DELCATH SYS INC) at 15.4%
  • Average position size: $8.15M

Sector Tilt

  • Health Care 94.7%
  • Industrials 5.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 7 added, 12 reduced, 8 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 69.7%
Other 30.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.45M $8.00M 7.48%
7.48%
Add
2 1.14M $7.12M 6.65%
6.65%
Reduce
3 485.99K $6.93M 6.47%
6.47%
Reduce
4 4.54M $6.63M 6.20%
6.20%
Reduce
5 2.82M $6.23M 5.82%
5.82%
Reduce
6 734.00K $6.11M 5.71%
5.71%
Reduce
7 13.96M $5.77M 5.39%
5.39%
New
8 378.42K $5.41M 5.06%
5.06%
New
9 300.00K $5.25M 4.91%
4.91%
Reduce
10 1.04M $4.96M 4.63%
4.63%
Hold
11 533.33K $4.55M 4.25%
4.25%
Hold
12 250.00K $4.02M 3.76%
3.76%
Hold
13 2.59M $3.97M 3.71%
3.71%
New
14 311.77K $3.72M 3.48%
3.48%
New
15 287.99K $3.42M 3.19%
3.19%
Reduce
16 926.02K $3.19M 2.98%
2.98%
Reduce
17 4.50M $3.15M 2.94%
2.94%
Add
18 1.88M $2.59M 2.42%
2.42%
New
19 621.48K $2.47M 2.31%
2.31%
Reduce
20 415.80K $1.91M 1.79%
1.79%
New
21 686.06K $1.63M 1.52%
1.52%
Reduce
22 2.30M $1.62M 1.52%
1.52%
New
23 903.61K $1.57M 1.47%
1.47%
New
24 1.55M $1.41M 1.32%
1.32%
New
25 607.80K $1.22M 1.14%
1.14%
Hold
26 1.51M $1.19M 1.11%
1.11%
Reduce
27 758.97K $781.74K 0.73%
0.73%
Hold
28 504.26K $776.56K 0.73%
0.73%
New
29 200.00K $660.00K 0.62%
0.62%
Hold
30 200.00K $510.00K 0.48%
0.48%
New
31 900.90K $167.57K 0.16%
0.16%
Hold
32 50.00K $72.50K 0.07%
0.07%
Reduce
33 100.00K $7.00K 0.01%
0.01%
Reduce

FAQ

What did Rosalind Advisors, Inc. buy in 2024-Q1?

In its 2024-Q1 13F filing, Rosalind Advisors, Inc. reported 33 equity positions worth $107.02M in aggregate; its largest disclosed positions were MYO ($8.00M), LYRA ($7.12M), MDWD ($6.93M).

How large is Rosalind Advisors, Inc.'s portfolio?

Rosalind Advisors, Inc. reported $107.02M of long equity holdings across 33 positions as of 2024-Q1. Top-10 holdings account for 58.3% of reported value.

What is Rosalind Advisors, Inc.'s investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rosalind-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →